Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Ayaka
    Junior Member
    • Apr 2014
    • 6

    #1

    Inconsistency between 16s sequencing with Illumina and qPCR

    Hi all, I would like to ask your opinion about inconsistent results regarding the abundance of certain bacteria between sequence data and qPCR using the same DNA samples.
    I have 2 treatments (A and B) and I want to know the effect of those treatments in the composition of the microbiota. In a first instance we did qPCR for certain bacterias and observed differences in the samples before and after the treatments with Wilcoxon signes rank test (paired test) p<0,05) so we went on sequencing the same DNA samples.
    The sequencing data was analyzed using proportion ( tested also with Wilcoxon signes rank test) and using the DESeq2 (differential abundance).
    The sequence data shows significative difference with the proportion analysis for treatment A but not forB (p-value=0.2754 ) and for treatment B but not A with DESeq2 ( Doing the analysis at OTU level, all the OTUs of treatment A had p-values >0.2).

    What can be the causes of this inconsistency between the analysis done with sequencing data and qPCR?
    and
    What is the most reliable result, qPCR or sequence data?


    thanks, Cheers.


    PS: We did pair end sequencing 300x2 with primers for the V3-V4 region with 70.000 sequence per sample ( 82 samples).
    The primers used for the qPCR were checked with BLAST and their specific for the bacterias of interest.
  • thermophile
    Senior Member
    • Apr 2015
    • 243

    #2
    1-sequencing isn't completely quantitative. It's sort of quantitative but with big caveats (pcr bias, primer bias, gene copy number, etc)

    2- are you sure that you're comparing apples to apples? How are you determining which OTUs are the OTUs that your qPCR is measuring (just taxonomic identification is not sufficient, you should be doing in silico PCR to determine which reads are which groups). All sequences that hit a particular qPCR primer should be combined for that analysis-don't run each OTU that hits each primer separately
    Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

    Comment

    • bunce
      Member
      • Sep 2012
      • 55

      #3
      Hi - I agree with Thermophile. One of the simplest things you can do is an in silico analysis of the binding sites in your bacterial targets for the V3-V4 primers. Over a number of PCR cycles even slight efficiency difference in primer binding can skew composition. You should also do multiple replicates (possibly across multiple dilutions). The way you generated the library can also skew the composition (e.g. using a 2-step PCR to add adapters). There are few things to try here but I would trust the quantitativeness of qPCR over read abundance. Cheers Mike

      Comment

      • Michael Love
        Senior Member
        • Jul 2013
        • 333

        #4
        a side note: I would recommend looking at effect size (LFC) rather than p-values. In fact, this is one of our points in the DESeq2 paper.

        short version: the p-value tells you a lot about power, and this is certainly going to be different across technology.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 08-06-2026, 07:41 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 08-03-2026, 10:13 AM
        0 responses
        33 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        43 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Working...